Kabadi Udaya M
Division of Endocrinology, Department of Medicine, Broadlawns Medical Center, Des Moines, IA University of Iowa Iowa City IA USA.
JBMR Plus. 2020 Oct 18;4(11):e10415. doi: 10.1002/jbm4.10415. eCollection 2020 Nov.
Vitamin D deficiency is reported in individuals with primary hyperparathyroidism (PHP). However, decreased 25OHD may be attributed to enhanced conversion into 1,25-hydroxyvitamin D [1,25(OH)D]. To examine vitamin D metabolism in individuals with PHP, serum calcium, PTH, 25OHD, and 1,25(OH)D levels were determined in 210 adults: 102 with PHP, 40 with normal 25OHD, and 68 with vitamin D deficiency. Concentrations were redetermined in 37 individuals with PHP following vitamin D supplementation and 43 patients postsurgery. Comparisons were conducted by Student's test and ANOVA. Correlations were assessed between PTH and 25OHD, 1,25(OH)D, and 1,25(OH)D/25OHD in individuals with PHP. Calcium, PTH, and 1,25(OH)D were higher ( < 0.001) in individuals with PHP (11.4 ± 0.4, 116 ± 21, 79 ± 6) than in individuals with normal 25OHD (9.6 ± 0.2, 49 ± 5, 57 ± 6) and vitamin D deficiency (9.3 ± 0.2, 62 ± 6, 32 ± 4). Compared with individuals with normal 25OHD (47 ± 5), 25OHD was lower (18 ± 3), but not different from subjects with vitamin D deficiency (15 ± 2). In individuals with PHP, vitamin D2 supplementation induced rises in 1,25(OH)D and calcium without lowering PTH, whereas postsurgery, calcium, PTH, 25OHD, and 1,25(OH)D normalized. Finally, in individuals with PHP, significant correlations ( < 0.01) were documented between PTH and calcium ( = 0.74), 25OHD ( = -0.43), 1,25(OH)D ( = 0.52), and 1,25(OH)D/25OHD ( = 0.46); and between 1,25(OH)D/25OHD and calcium ( = 0.47). Subnormal 25OHD in most individuals with PHP may be attributed to enhanced conversion to 1,25(OH)D-not "true" vitamin D deficiency-although in some patients, both PHP and vitamin D deficiency coexisted. Moreover, vitamin D supplementation exaggerated hypercalcemia in individuals with PHP. © 2020 The Author. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
据报道,原发性甲状旁腺功能亢进症(PHP)患者存在维生素D缺乏的情况。然而,25羟维生素D(25OHD)水平降低可能是由于其向1,25-二羟维生素D [1,25(OH)D] 的转化增强所致。为研究PHP患者的维生素D代谢情况,测定了210名成年人的血清钙、甲状旁腺激素(PTH)、25OHD和1,25(OH)D水平:其中102例为PHP患者,40例25OHD水平正常,68例存在维生素D缺乏。对37例补充维生素D后的PHP患者和43例术后患者重新测定了上述指标。采用学生t检验和方差分析进行比较。评估了PHP患者中PTH与25OHD、1,25(OH)D以及1,25(OH)D/25OHD之间的相关性。PHP患者(11.4±0.4、116±21、79±6)的钙、PTH和1,25(OH)D水平高于25OHD水平正常者(9.6±0.2、49±5、57±6)和维生素D缺乏者(9.3±0.2、62±6、32±4)(P<0.001)。与25OHD水平正常者(47±5)相比,PHP患者的25OHD水平较低(18±3),但与维生素D缺乏者无差异(15±2)。在PHP患者中,补充维生素D2可使1,25(OH)D和钙水平升高,但不会降低PTH,而术后钙、PTH、25OHD和1,25(OH)D恢复正常。最后,在PHP患者中,PTH与钙(r=0.74)、25OHD(r=-0.43)、1,25(OH)D(r=0.52)以及1,25(OH)D/25OHD(r=0.46)之间存在显著相关性(P<0.01);1,25(OH)D/25OHD与钙之间也存在显著相关性(r=0.47)。大多数PHP患者25OHD水平低于正常可能是由于其向1,25(OH)D的转化增强,而非“真正的”维生素D缺乏,不过在一些患者中,PHP和维生素D缺乏并存。此外,补充维生素D会使PHP患者的高钙血症加重。© 2020作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。